In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.

[EX Q]: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``National Emergency Centers 
Establishment Act''.

SEC. 2. ESTABLISHMENT OF NATIONAL EMERGENCY CENTERS.

    (a) In General.--In accordance with the requirements of this Act, 
the Secretary of Homeland Security shall establish not fewer than 6 
national emergency centers on military installations.
    (b) Purpose of National Emergency Centers.--The purpose of a 
national emergency center shall be to use existing infrastructure--
            (1) to provide temporary housing, medical, and humanitarian 
        assistance to individuals and families dislocated due to an 
        emergency or major disaster;
            (2) to provide centralized locations for the purposes of 
        training and ensuring the coordination of Federal, State, and 
        local first responders;
            (3) to provide centralized locations to improve the 
        coordination of preparedness, response, and recovery efforts of 
        government, private, and not-for-profit entities and faith-
        based organizations; and
            (4) to meet other appropriate needs, as determined by the 
        Secretary of Homeland Security.

SEC. 3. DESIGNATION OF MILITARY INSTALLATIONS AS NATIONAL EMERGENCY 
              CENTERS.

    (a) In General.--Not later than 60 days after the date of the 
enactment of this Act, the Secretary of Homeland Security, in 
consultation with the Secretary of Defense, shall designate not fewer 
than 6 military installations as sites for the establishment of 
national emergency centers.
    (b) Minimum Requirements.--A site designated as a national 
emergency center shall be--
            (1) capable of meeting for an extended period of time the 
        housing, health, transportation, education, and humanitarian 
        needs of a large number of individuals affected by an emergency 
        or major disaster;
            (2) environmentally safe and shall not pose a health risk 
        to individuals who may use the center;
            (3) capable of accommodating major disaster preparedness 
        and response drills, operations, and procedures; and
            (4) easily accessible at all times, including during an 
        emergency or major disaster.
    (c) Location of National Emergency Centers.--There shall be 
established not fewer than one national emergency center in each of the 
following areas:
            (1) The area consisting of Federal Emergency Management 
        Agency Regions I, II, and III.
            (2) The area consisting of Federal Emergency Management 
        Agency Region IV.
            (3) The area consisting of Federal Emergency Management 
        Agency Regions V and VII.
            (4) The area consisting of Federal Emergency Management 
        Agency Region VI.
            (5) The area consisting of Federal Emergency Management 
        Agency Regions VIII and X.
            (6) The area consisting of Federal Emergency Management 
        Agency Region IX.
    (d) Preference for Designation of Closed Military Installations.--
Wherever possible, the Secretary of Homeland Security, in consultation 
with the Secretary of Defense, shall designate a closed military 
installation as a site for a national emergency center. If the 
Secretaries of Homeland Security and Defense jointly determine that 
there is not a sufficient number of closed military installations that 
meet the requirements of subsections (b) and (c), the Secretaries shall 
jointly designate portions of existing military installations other 
than closed military installations as national emergency centers.
    (e) Transfer of Control of Closed Military Installations.--If a 
closed military installation is designated as a national emergency 
center, not later than 180 days after the date of designation, the 
Secretary of Defense shall transfer to the Secretary of Homeland 
Security administrative jurisdiction over such closed military 
installation.
    (f) Cooperative Agreement for Joint Use of Existing Military 
Installations.--If an existing military installation other than a 
closed military installation is designated as a national emergency 
center, not later than 180 days after the date of designation, the 
Secretary of Homeland Security and the Secretary of Defense shall enter 
into a cooperative agreement to provide for the establishment of the 
national emergency center.
    (g) Reports.--
            (1) Preliminary report.-- Not later than 90 days after the 
        date of the enactment of this Act, the Secretary of Homeland 
        Security, acting jointly with the Secretary of Defense, shall 
        submit to Congress a report that contains for each designated 
        site--
                    (A) an outline of the reasons why the site was 
                selected;
                    (B) an outline of the need to construct, repair, or 
                update any existing infrastructure at the site;
                    (C) an outline of the need to conduct any necessary 
                environmental clean-up at the site;
                    (D) an outline of preliminary plans for the 
                transfer of control of the site from the Secretary of 
                Defense to the Secretary of Homeland Security, if 
                necessary under subsection (e); and
                    (E) an outline of preliminary plans for entering 
                into a cooperative agreement for the establishment of a 
                national emergency center at the site, if necessary 
                under subsection (f).
            (2) Update report.--Not later than 120 days after the date 
        of the enactment of this Act, the Secretary of Homeland 
        Security, acting jointly with the Secretary of Defense, shall 
        submit to Congress a report that contains for each designated 
        site--
                    (A) an update on the information contained in the 
                report as required by paragraph (1);
                    (B) an outline of the progress made toward the 
                transfer of control of the site, if necessary under 
                subsection (e);
                    (C) an outline of the progress made toward entering 
                a cooperative agreement for the establishment of a 
                national emergency center at the site, if necessary 
                under subsection (f); and
                    (D) recommendations regarding any authorizations 
                and appropriations that may be necessary to provide for 
                the establishment of a national emergency center at the 
                site.
            (3) Final report.--Not later than 1 year after the date of 
        the enactment of this Act, the Secretary of Homeland Security, 
        acting jointly with the Secretary of Defense, shall submit to 
        Congress a report that contains for each designated site--
                    (A) finalized information detailing the transfer of 
                control of the site, if necessary under subsection (e);
                    (B) the finalized cooperative agreement for the 
                establishment of a national emergency center at the 
                site, if necessary under subsection (f); and
                    (C) any additional information pertinent to the 
                establishment of a national emergency center at the 
                site.
            (4) Additional reports.--The Secretary of Homeland 
        Security, acting jointly with the Secretary of Defense, may 
        submit to Congress additional reports as necessary to provide 
        updates on steps being taken to meet the requirements of this 
        Act.

SEC. 4. LIMITATIONS ON STATUTORY CONSTRUCTION.

    This Act does not affect--
            (1) the authority of the Federal Government to provide 
        emergency or major disaster assistance or to implement any 
        disaster mitigation and response program, including any program 
        authorized by the Robert T. Stafford Disaster Relief and 
        Emergency Assistance Act (42 U.S.C. 5121 et seq.); or
            (2) the authority of a State or local government to respond 
        to an emergency.

SEC. 5. AUTHORIZATION OF APPROPRIATIONS.

    There is authorized to be appropriated $125,000,000 for each of 
fiscal years 2006 and 2007 to carry out this Act. Such funds shall 
remain available until expended.

SEC. 6. DEFINITIONS.

    In this Act, the following definitions apply:
            (1) Closed military installation.--The term ``closed 
        military installation'' means a military installation, or 
        portion thereof, approved for closure in 2005 under the Defense 
        Base Closure and Realignment Act of 1990 (part A of title XXIX 
        of Public Law 101-510; 10 U.S.C. 2687 note).
            (2) Emergency.--The term ``emergency'' has the meaning 
        given such term in section 102 of the Robert T. Stafford 
        Disaster Relief and Emergency Assistance Act (42 U.S.C. 5122).
            (3) Major disaster.--The term ``major disaster'' has the 
        meaning given such term in section 102 of the Robert T. 
        Stafford Disaster Relief and Emergency Assistance Act (42 
        U.S.C. 5122).
            (4) Military installation.--The term ``military 
        installation'' has the meaning given such term in section 2910 
        of the Defense Base Closure and Realignment Act of 1990 (part A 
        of title XXIX of Public Law 101-510; 10 U.S.C. 2687 note).
[EX A]: National Emergency Centers Establishment Act - Directs the Secretary of Homeland Security to establish at least six national emergency centers on mililtary installations to provide: (1) temporary housing, medical, and humanitarian assistance to individuals and families dislocated due to an emergency or major disaster; and (2) centralized locations for the training and coordination of federal, state, and local first responders, and to improve coordination of preparedness, response, and recovery efforts of government, private, and not-for-profit entities and faith-based organizations.

Requires the use of such centers to meet other appropriate needs determined by the Secretary.

[EX Q]: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Protecting Consumer Access to 
Generic Drugs Act of 2007''.

SEC. 2. UNFAIR AND DECEPTIVE ACTS AND PRACTICES RELATED TO NEW DRUG 
              APPLICATIONS.

    (a) Conduct Prohibited.--It shall be unlawful for any person to 
directly or indirectly be a party to any agreement resolving or 
settling a patent infringement claim in which--
            (1) an ANDA filer receives anything of value; and
            (2) the ANDA filer agrees not to research, develop, 
        manufacture, market, or sell, for any period of time, the drug 
        that is to be manufactured under the ANDA involved and is the 
        subject of the patent infringement claim.
    (b) Exceptions.--Notwithstanding subsection (a)(1), subsection (a) 
does not prohibit a resolution or settlement of a patent infringement 
claim in which the value received by the ANDA filer includes no more 
than--
            (1) the right to market the drug that is to be manufactured 
        under the ANDA involved and is the subject of the patent 
        infringement claim, before the expiration of--
                    (A) the patent that is the basis for the patent 
                infringement claim; or
                    (B) any other statutory exclusivity that would 
                prevent the marketing of such drug; and
            (2) the waiver of a patent infringement claim for damages 
        based on prior marketing of such drug.
    (c) Enforcement.--A violation of subsection (a) shall be treated as 
an unfair and deceptive act or practice and an unfair method of 
competition in or affecting interstate commerce prohibited under 
section 5 of the Federal Trade Commission Act (15 U.S.C. 45). The 
Federal Trade Commission shall enforce this Act in the same manner, by 
the same means, and with the same jurisdiction as though all applicable 
terms and provisions of the Federal Trade Commission Act were 
incorporated into and made a part of this Act.
    (d) Definitions.--In this section:
            (1) Agreement.--The term ``agreement'' means anything that 
        would constitute an agreement for purposes of section 5 of the 
        Federal Trade Commission Act (15 U.S.C. 45).
            (2) Agreement resolving or settling.--The term ``agreement 
        resolving or settling'', in reference to a patent infringement 
        claim, includes any agreement that is contingent upon, provides 
        a contingent condition for, or is otherwise related to the 
        resolution or settlement of the claim.
            (3) ANDA.--The term ``ANDA'' means an abbreviated new drug 
        application for the approval of a new drug under section 505(j) 
        of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355(j)).
            (4) ANDA filer.--The term ``ANDA filer'' means a party that 
        has filed an ANDA with the Food and Drug Administration.
            (5) Patent infringement.--The term ``patent infringement'' 
        means infringement of any patent or of any filed patent 
        application, extension, reissuance, renewal, division, 
        continuation, continuation in part, reexamination, patent term 
        restoration, patent of addition, or extension thereof.
            (6) Patent infringement claim.--The term ``patent 
        infringement claim'' means any allegation made to an ANDA 
        filer, whether or not included in a complaint filed with a 
        court of law, that its ANDA or drug to be manufactured under 
        such ANDA may infringe any patent.

SEC. 3. FTC RULEMAKING.

    The Federal Trade Commission may, by rule promulgated under section 
553 of title 5, United States Code, exempt certain agreements described 
in section 2 if the Commission finds such agreements to be in 
furtherance of market competition and for the benefit of consumers. 
Consistent with the authority of the Commission, such rules may include 
interpretive rules and general statements of policy with respect to the 
practices prohibited under section 2.

SEC. 4. FORFEITURE OF 180-DAY EXCLUSIVITY PERIOD UNDER THE FFDCA.

    Section 505(j)(5)(D)(i) of the Federal Food, Drug, and Cosmetic Act 
(21 U.S.C. 355(j)(5)(D)(i)) is amended--
            (1) in subclause (I)(bb)--
                    (A) by redesignating subitem (CC) as subitem (EE); 
                and
                    (B) by inserting after subitem (BB) the following:

                                                    ``(CC) In a 
                                                declaratory judgment 
                                                action described in 
                                                subitem (AA), a court 
                                                dismisses the action 
                                                for lack of subject 
                                                matter jurisdiction, 
                                                either with or without 
                                                prejudice.

                                                    ``(DD) The 
                                                applicant files with 
                                                the Secretary a 
                                                covenant by the patent 
                                                owner that the patent 
                                                owner will not sue the 
                                                applicant for 
                                                infringement with 
                                                respect to the 
                                                patent.''; and

            (2) in subclause (V), by inserting ``section 2 of the 
        Protecting Consumer Access to Generic Drugs Act of 2007 or'' 
        after ``that the agreement has violated''.

SEC. 5. NOTICE AND CERTIFICATION OF AGREEMENTS.

    (a) Notice of All Agreements.--Section 1112(c)(2) of the Medicare 
Prescription Drug, Improvement, and Modernization Act of 2003 (21 
U.S.C. 3155 note) is amended by--
            (1) striking ``the Commission the'' and inserting ``the 
        Commission (1) the''; and
            (2) inserting before the period at the end the following: 
        ``; and (2) a description of the subject matter of any other 
        agreement the parties enter into within 30 days of an entering 
        into an agreement covered by subsection (a) or (b)''.
    (b) Certification of Agreements.--Section 1112 of such Act is 
amended by adding at the end the following:
    ``(d) Certification.--The Chief Executive Officer or the company 
official responsible for negotiating any agreement required to be filed 
under subsection (a), (b), or (c) shall execute and file with the 
Assistant Attorney General and the Commission a certification as 
follows: `I declare under penalty of perjury that the following is true 
and correct: The materials filed with the Federal Trade Commission and 
the Department of Justice under section 1112 of subtitle B of title XI 
of the Medicare Prescription Drug, Improvement, and Modernization Act 
of 2003, with respect to the agreement referenced in this 
certification: (1) represent the complete, final, and exclusive 
agreement between the parties; (2) include any ancillary agreements 
that are contingent upon, provide a contingent condition for, or are 
otherwise related to, the referenced agreement; and (3) include written 
descriptions of any oral agreements, representations, commitments, or 
promises between the parties that are responsive to subsection (a) or 
(b) of such section 1112 and have not been reduced to writing.'.''.
[EX A]: Protecting Consumer Access to Generic Drugs Act of 2007 - Prohibits, as an unfair and deceptive act or practice and an unfair method of competition in or affecting interstate commerce, any person from being a party to any agreement resolving or settling a patent infringement claim in which: (1) an abbreviated new drug (generic) application filer receives anything of value; and (2) such filer agrees not to research, develop, manufacture, market or sell the generic drug. Excludes a resolution or settlement that includes no more than: (1) the right to market the generic drug before the expiration of the patent or other exclusivity period; or (2) the waiver of a patent infringement claim for damages.

Authorizes the Federal Trade Commission (FTC) to exempt agreements in furtherance of market competition and for the benefit of consumers.

Amends the Federal Food, Drug, and Cosmetic Act to provide that a generic drug applicant forfeits market exclusivity for failing to market the drug 75 days after: (1) a court dismisses a declaratory judgment action for lack of subject matter jurisdiction; or (2) the applicant files with the Secretary of Health and Human Services a covenant that the patent owner will not sue the applicant for patent infringement. Deems an applicant to have forfeited market exclusivity if the applicant enters into an agreement that violates this Act.

Amends the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 to revise reporting requirements related to agreements between a generic drug applicant and a brand name drug company to include: (1) a description of the subject matter of other agreements between the parties; and (2) a certification that the materials filed represent the complete, final, and exclusive agreement between the parties.

[EX Q]: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Financial Information Privacy Act of 
1999''.

SEC. 2. DEFINITIONS.

    In this Act--
            (1) the term ``covered person'' means a person that is 
        subject to the jurisdiction of any of the Federal financial 
        regulatory authorities; and
            (2) the term ``Federal financial regulatory authorities'' 
        means--
                    (A) each of the Federal banking agencies, as that 
                term is defined in section 3(z) of the Federal Deposit 
                Insurance Act; and
                    (B) the Securities and Exchange Commission.

SEC. 3. PRIVACY OF CONFIDENTIAL CUSTOMER INFORMATION.

    (a) Rulemaking.--The Federal financial regulatory authorities shall 
jointly issue final rules to protect the privacy of confidential 
customer information relating to the customers of covered persons, not 
later than 270 days after the date of enactment of this Act (and shall 
issue a notice of proposed rulemaking not later than 150 days after the 
date of enactment of this Act), which rules shall--
            (1) define the term ``confidential customer information'' 
        to be personally identifiable data that includes transactions, 
        balances, maturity dates, payouts, and payout dates, of--
                    (A) deposit and trust accounts;
                    (B) certificates of deposit;
                    (C) securities holdings; and
                    (D) insurance policies;
            (2) require that a covered person may not disclose or share 
        any confidential customer information to or with any affiliate 
        or agent of that covered person if the customer to whom the 
        information relates has provided written notice, as described 
        in paragraphs (4) and (5), to the covered person prohibiting 
        such disclosure or sharing--
                    (A) with respect to an individual that became a 
                customer on or after the effective date of such rules, 
                at the time at which the business relationship between 
                the customer and the covered person is initiated and at 
                least annually thereafter; and
                    (B) with respect to an individual that was a 
                customer before the effective date of such rules, at 
                such time thereafter that provides a reasonable and 
                informed opportunity to the customer to prohibit such 
                disclosure or sharing and at least annually thereafter;
            (3) require that a covered person may not disclose or share 
        any confidential customer information to or with any person 
        that is not an affiliate or agent of that covered person unless 
        the covered person has first--
                    (A) given written notice to the customer to whom 
                the information relates, as described in paragraphs (4) 
                and (5); and
                    (B) obtained the informed written or electronic 
                consent of that customer for such disclosures or 
                sharing;
            (4) require that the covered person provide notices and 
        consent acknowledgments to customers, as required by this 
        section, in separate and easily identifiable and 
        distinguishable form;
            (5) require that the covered person provide notice as 
        required by this section to the customer to whom the 
        information relates that describes what specific types of 
        information would be disclosed or shared, and under what 
        general circumstances, to what specific types of businesses or 
        persons, and for what specific types of purposes such 
        information could be disclosed or shared;
            (6) require that the customer to whom the information 
        relates be provided with access to the confidential customer 
        information that could be disclosed or shared so that the 
        information may be reviewed for accuracy and corrected or 
        supplemented;
            (7) require that, before a covered person may use any 
        confidential customer information provided by a third party 
        that engages, directly or indirectly, in activities that are 
        financial in nature, as determined by the Federal financial 
        regulatory authorities, the covered person shall take 
        reasonable steps to assure that procedures that are 
        substantially similar to those described in paragraphs (2) 
        through (6) have been followed by the provider of the 
        information (or an affiliate or agent of that provider); and
            (8) establish a means of examination for compliance and 
        enforcement of such rules and resolving consumer complaints.
    (b) Limitation.--The rules prescribed pursuant to subsection (a) 
may not prohibit the release of confidential customer information--
            (1) that is essential to processing a specific financial 
        transaction that the customer to whom the information relates 
        has authorized;
            (2) to a governmental, regulatory, or self-regulatory 
        authority having jurisdiction over the covered financial entity 
        for examination, compliance, or other authorized purposes;
            (3) to a court of competent jurisdiction;
            (4) to a consumer reporting agency, as defined in section 
        603 of the Fair Credit Reporting Act for inclusion in a 
        consumer report that may be released to a third party only for 
        a purpose permissible under section 604 of that Act; or
            (5) that is not personally identifiable.
    (c) Construction.--Nothing in this section or the rules prescribed 
under this section shall be construed to amend or alter any provision 
of the Fair Credit Reporting Act.
[EX A]:
Financial Information Privacy Act of 1999 - Directs the Federal financial regulatory authorities (banking regulatory agencies and the Securities and Exchange Commission (SEC)) to jointly issue final rules to protect the privacy of confidential information relating to customers of institutions under their respective jurisdictions (covered institution). 
Mandates that such rules: (1) prohibit a covered institution from disclosing or sharing confidential customer information with any affiliate or agent if the customer has provided a written notice which forbids such disclosure; (2) prohibit a covered institution from disclosing or sharing confidential customer information with a non-affiliate or non-agent unless the customer has provided written or electronic consent; (3) require the covered institution to disclose to the customer the specific type of information disclosed or shared, under what circumstances, to what specific types of businesses, and for what types of purposes; (4) require customer access to information that could be disclosed so that it may be reviewed for accuracy and supplementation; and (5) establish a compliance and enforcement mechanism that includes consumer complaint resolution. 
Cites circumstances under which such information may be released.